Korbová L, Kohout J, Malis F, Balas V, Cízková J, Marek J, Cihák A
Gut. 1977 Nov;18(11):913-8. doi: 10.1136/gut.18.11.913.
Cycloheximide, 5-azacytidine, and 4-methoxybenzoyl-beta-bromoarylate (Cytembena) block the development of experimental acute pancreatitis in rats when mediated by the administration of 5% bile solution into the pancreas in vivo. Six hours after drug treatment the pathological changes, evaluated macroscopically or using histological sections of the pancreas, were significantly decreased. The drugs affected the amount of abdominal fluid and lowered its lipase and amylase activity. The known inhibitory mechanism of the active drugs and the possible advantage of cycloheximide for clinical use are briefly mentioned.
当通过在体内向胰腺注射5%胆汁溶液介导实验性急性胰腺炎时,环己酰亚胺、5-氮杂胞苷和4-甲氧基苯甲酰-β-溴芳酯(赛特贝纳)可阻断大鼠实验性急性胰腺炎的发展。药物治疗6小时后,通过肉眼评估或使用胰腺组织切片评估的病理变化显著减轻。这些药物影响腹腔液的量,并降低其脂肪酶和淀粉酶活性。文中简要提及了活性药物已知的抑制机制以及环己酰亚胺在临床应用中的可能优势。